Clinical Trial Update: Phase II Clinical Study of BC006 in Patients With Idiopathic Pulmonary Fibrosis [Phase 2]

View source ↗

Summary

Phase II clinical trial of BC006 for idiopathic pulmonary fibrosis is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Idiopathic Pulmonary Fibrosis

Drugs mentioned

• BC006

Snippet

Sponsor: Dragonboat Biopharmaceutical Company Limited | Conditions: Idiopathic Pulmonary Fibrosis (IPF) | Phase 2 | Status: NOT_YET_RECRUITING